Safety of the 2011–12, 2012–13, and 2013–14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS

Vaccine

Volumn 34, Issue 37, 2016, Pages 4450-4459

  Louik, Carol ^a,d   Kerr, Stephen ^a,d   Van Bennekom, Carla M ^a,d   Chambers, Christina ^b,d   Jones, Kenneth L ^b,d   Schatz, Michael ^c,d   Mitchell, Allen A ^a,d  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c American Academy of Allergy   (United States)

^d Vaccines and Medications in Pregnancy Surveillance System (VAMPSS)   (United States)

Author keywords

Birth defects; Pregnancy; Preterm delivery; Seasonal influenza vaccine

Indexed keywords

FOLIC ACID; ILLICIT DRUG; INFLUENZA VACCINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASTHMA; ATRIOVENTRICULAR CANAL; ATRIOVENTRICULAR SEPTAL DEFECT; BODY MASS; CALIFORNIA; COFFEE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG SAFETY; DRUG USE; EDUCATIONAL STATUS; FAMILY HISTORY; FAMILY INCOME; FEMALE; FETUS RISK; FIRST TRIMESTER PREGNANCY; GENITAL HERPES; GESTATIONAL AGE; HUMAN; HYPERTENSION; INFECTION; INFERTILITY THERAPY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MASSACHUSETTS; MATERNAL SMOKING; NAUSEA AND VOMITING; NEW YORK; OBSTETRIC DELIVERY; OMPHALOCELE; PENNSYLVANIA; PREGNANCY; PREGNANCY TOXEMIA; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; RACE; SEASONAL INFLUENZA; SECOND TRIMESTER PREGNANCY; SPONTANEOUS ABORTION; TENNESSEE; THIRD TRIMESTER PREGNANCY; CASE CONTROL STUDY; CONGENITAL ABNORMALITIES; INFLUENZA, HUMAN; PREMATURE BIRTH; PROSPECTIVE STUDY; RISK; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PREGNANCY; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84990931842     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.06.078     Document Type: Article

References (51)

1. [1] Acs, N., Banhidy, F., Puho, E., Czeizel, A.E., Maternal influenza during pregnancy and risk of congenital abnormalities in offspring. Birth Defects Res A: Clin Mol Teratol 73 (2005), 989–996.
2. [2] Harper, S.A., Fukuda, K., Uyeki, T.M., Cox, N.J., Bridges, C.B., Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54 (2005), 1–40.
3. [3] Jamieson, D.J., Theiler, R.N., Rasmussen, S.A., Emerging infections and pregnancy. Emerg Infect Dis 12 (2006), 1638–1643.
4. [4] Rasmussen, S.A., Jamieson, D.J., Bresee, J.S., Pandemic influenza and pregnant women. Emerg Infect Dis 14 (2008), 95–100.
5. [5] CDC. Vaccinations to prevent diseases: universally recommended vaccinations. In: Services UDoHaH, ed. Atlanta, GA; 2011.
6. [6] Goldfarb, I., Panda, B., Wylie, B., Riley, L., Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol 204 (2011), S112–S115.
7. [7] Lynch, M.M., Mitchell, E.W., Williams, J.L., et al. Pregnant and recently pregnant women's perceptions about influenza A pandemic (H1N1) 2009: implications for public health and provider communication. Matern Child Health J 16 (2011), 1657–1664.
8. [8] Naleway, A.L., Smith, W.J., Mullooly, J.P., Delivering influenza vaccine to pregnant women. Epidemiol Rev 28 (2006), 47–53.
9. [9] Ding, H., Black, C.L., Ball, S., et al. Influenza vaccination coverage among pregnant women – United States, 2013–14 influenza season. Morbid Mortal Wkly Rep 63 (2014), 816–821.
10. [10] Eppes, C., Wu, A., You, W., Cameron, K.A., Garcia, P., Grobman, W., Barriers to influenza vaccination among pregnant women. Vaccine 31 (2013), 2874–2878.
11. [11] Ding, H., Ball, S., Donahue, S., et al. Influenza vaccination coverage among pregnant women—United States, 2012–13 influenza season. Morbid Mortal Wkly Rep 62 (2013), 787–792.
12. [12] Schatz, M., Chambers, C.D., Jones, K.L., Louik, C., Mitchell, A.A., Safety of influenza immunizations and treatment during pregnancy: the vaccines and medications in pregnancy surveillance system. Am J Obstet Gynecol 204 (2011), S64–S68.
13. [13] Chambers, C.D., Johnson, D., Xu, R., et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine 31 (2013), 5026–5032.
14. [14] Louik, C., Ahrens, K., Kerr, S., et al. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Vaccine 31 (2013), 5033–5040.
15. [15] Louik, C., Lin, A.E., Werler, M.M., Hernandez-Diaz, S., Mitchell, A.A., First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356 (2007), 2675–2683.
16. [16] Mitchell, A.A., Rosenberg, L., Shapiro, S., Slone, D., Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. JAMA 245 (1981), 2311–2314.
17. [17] Werler, M.M., Hayes, C., Louik, C., Shapiro, S., Mitchell, A.A., Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150 (1999), 675–682.
18. [18] Mitchell, A.A., Cottler, L.B., Shapiro, S., Effect of questionnaire design on recall of drug exposure during pregnancy. Am J Epidemiol 123 (1986), 670–676.
19. [19] Mitchell, A.A., Studies of drug-induced birth defects. Strom, B.L., Kimmel, S.E., Hennessy, S., (eds.) Pharmacoepidemiology, 5th ed., 2012, Wiley-Blackwell, West Sussex (UK), 487–504.
20. [20] Jacobs, D.C., Louik, C., Dynkin, N., Mitchell, A., Accuracy of maternal report of influenza vaccine exposure in pregnancy. Pharmacoepidemiol Drug Saf, 20, 2011, S360.
21. [21] Louik, C., Chambers, C., Jacobs, D., et al. Influenza vaccine safety in pregnancy: can we identify exposures?. Pharmacoepidemiol Drug Saf 22 (2013), 33–39.
22. [22] Mansson, R., Joffe, M.M., Sun, W., Hennessy, S., On the estimation and use of propensity scores in case-control and case-cohort studies. Am J Epidemiol 166 (2007), 332–339.
23. [23] Cole, J.A., Ephross, S.A., Cosmatos, I.S., Walker, A.M., Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 16 (2007), 1075–1085.
24. [24] Ahrens, K.A., Louik, C., Kerr, S., Mitchell, A.A., Werler, M.M., Seasonal influenza vaccination during pregnancy and the risks of preterm delivery and small for gestational age birth. Paediatr Perinat Epidemiol 28 (2014), 498–509.
25. [25] Fell, D.B., Platt, R.W., Lanes, A., et al. Fetal death and preterm birth associated with maternal influenza vaccination: systematic review. BJOG 122 (2015), 17–26.
26. [26] Chambers C, Johnson D, Xu R, et al. Safety of the 2010,11, 2011,12, 2012,13, and 2013,14 seasonal influenza vaccines in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants; 2016.
27. [27] Polyzos, K.A., Konstantelias, A.A., Pitsa, C.E., Falagas, M.E., Maternal influenza vaccination and risk for congenital malformations: a systematic review and meta-analysis. Obstet Gynecol 126 (2015), 1075–1084.
28. [28] Beau, A.B., Hurault-Delarue, C., Vidal, S., et al. Pandemic A/H1N1 influenza vaccination during pregnancy: a comparative study using the EFEMERIS database. Vaccine 32 (2014), 1254–1258.
29. [29] Fell, D.B., Sprague, A.E., Liu, N., et al. H1N1 influenza vaccination during pregnancy and fetal and neonatal outcomes. Am J Public Health 102 (2012), e33–e40.
30. [30] Haberg, S.E., Trogstad, L., Gunnes, N., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 368 (2013), 333–340.
31. [31] Heikkinen, T., Young, J., van Beek, E., et al. Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study. Am J Obstet Gynecol 207 (2012), 177e1–177e8.
32. [32] Kallen, B., Olausson, P.O., Vaccination against H1N1 influenza with Pandemrix® during pregnancy and delivery outcome: a Swedish register study. BJOG 119 (2012), 1583–1590.
33. [33] Launay, O., Krivine, A., Charlier, C., et al. Low rate of pandemic A/H1N1 2009 influenza infection and lack of severe complication of vaccination in pregnant women: a prospective cohort study. PLoS ONE, 7, 2012, e52303.
34. [34] Lin, T.H., Lin, S.Y., Lin, C.H., et al. AdimFlu-S® influenza A (H1N1) vaccine during pregnancy: the Taiwanese Pharmacovigilance Survey. Vaccine 30 (2012), 2671–2675.
35. [35] Ludvigsson, J.F., Zugna, D., Cnattingius, S., et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol 28 (2013), 579–588.
36. [36] Oppermann, M., Fritzsche, J., Weber-Schoendorfer, C., et al. A(H1N1)v2009: a controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine 30 (2012), 4445–4452.
37. [37] Pasternak, B., Svanstrom, H., Molgaard-Nielsen, D., et al. Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark. BMJ, 344, 2012, e2794.
38. [38] Pasternak, B., Svanstrom, H., Molgaard-Nielsen, D., et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA 308 (2012), 165–174.
39. [39] Richards, J.L., Hansen, C., Bredfeldt, C., et al. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clin Infect Dis 56 (2013), 1216–1222.
40. [40] Rubinstein, F., Micone, P., Bonotti, A., et al. Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study. BMJ, 346, 2013, f393.
41. [41] Sammon, C.J., Snowball, J., McGrogan, A., de Vries, C.S., Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD. PLoS ONE, 7, 2012, e51734.
42. [42] Cleary, B.J., Rice, U., Eogan, M., Metwally, N., McAuliffe, F., 2009 A/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes – a historical cohort study. Eur J Obstet Gynecol Reprod Biol 178 (2014), 163–168.
43. [43] Trotta, F., Da Cas, R., Spila Alegiani, S., et al. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ, 348, 2014, g3361.
44. [44] Dodds, L., Macdonald, N., Scott, J., Spencer, A., Allen, V.M., McNeil, S., The association between influenza vaccine in pregnancy and adverse neonatal outcomes. J Obstet Gynaecol Can 34 (2012), 714–720.
45. [45] Irving, S.A., Kieke, B.A., Donahue, J.G., et al. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol 121 (2013), 159–165.
46. [46] Omer, S.B., Goodman, D., Steinhoff, M.C., et al. Maternal influenza immunization and reduced likelihood of prematurity and small for gestational age births: a retrospective cohort study. PLoS Med, 8, 2011, e1000441.
47. [47] Sheffield, J.S., Greer, L.G., Rogers, V.L., et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol 120 (2012), 532–537.
48. [48] Munoz, F.M., Greisinger, A.J., Wehmanen, O.A., et al. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 192 (2005), 1098–1106.
49. [49] Legge, A., Dodds, L., MacDonald, N.E., Scott, J., McNeil, S., Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ 186 (2014), E157–E164.
50. [50] Armstrong, P.K., Dowse, G.K., Effler, P.V., et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open, 1, 2011, e000016.
51. [51] Bednarczyk, R.A., Adjaye-Gbewonyo, D., Omer, S.B., Safety of influenza immunization during pregnancy for the fetus and the neonate. Am J Obstet Gynecol 207 (2012), S38–S46.